Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.79+0.09 (+0.61%)
Close on Nov 17, 2026Market cap $12.34BP/E 27.1Yield 0.57%
Dr Reddys Laboratories price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Dr Reddys Laboratories's price to book ratio was 3.1× on Nov 11, 2026, against 3.1× a year earlier. Over the last 3 years it ranged from 2.5× to 4.1×, with a median of 3.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.1× | −0.1 |
| 2025 | Dec 31, 2025 | 3.2× | −0.8 |
| 2024 | Dec 31, 2024 | 4.0× | – |
See a number that looks wrong?